A critical advance in cancer investigation is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital tumor protector protein is frequently lost in several forms of cancer, leading https://socialtechnet.com/story7548878/nanobodies-revive-the-p53-protein-the-new-hope-for-malignant-management